HPV vaccinations up, but so are HPV-related cancer cases, CDC finds

While an increasing number of adolescents received HPV vaccinations between 2016-17, other data highlights a spike in HPV-related cancer, according to two separate Morbidity and Mortality Weekly Reports from the CDC published Aug. 24.

Here are three things to know:

1. The CDC reported the number of adolescents ages 12 to 17 who completed the HPV vaccine series grew by 5 percent between 2016-17.

2. In 2017, about 66 percent of adolescents ages 13 to 17 received the first HPV vaccine dose, and about 49 percent had completed the total series.

3. The CDC in another report indicated the number of HPV-associated cancers climbed from 30,000 in 1999 to 43,000 in 2015 in the 16 to 23 age groups.

More articles on clinical leadership and infection control: 

Physician likely 1st to contract Ebola in Congo conflict zone

California fines 13 hospitals $1M-plus for patient safety issues

How University of Utah Health cut sepsis costs by 10%